Get Your Personalized Supplement StackSupplement Stack Quiz

Ovaries

Also known as: Ovarian extract, Ovarian tissue supplement, Flavonoids, Myo-inositol

Overview

While 'Ovaries' as a direct supplement ingredient is not a chemical compound, the term often refers to supplements containing compounds that support ovarian function, primarily myo-inositol and various flavonoids. These supplements are categorized under reproductive health, fertility enhancers, and hormonal modulators. They are primarily used to improve fertility outcomes, especially in women undergoing assisted reproductive technologies (ART) like in vitro fertilization (IVF), and to manage conditions such as polycystic ovary syndrome (PCOS). The key aim of these supplements is to enhance oocyte quality, fertilization rates, and hormonal balance. Research maturity for myo-inositol is moderate to high, with numerous randomized controlled trials (RCTs) and meta-analyses supporting its efficacy. For flavonoids, evidence is also growing, particularly in the context of PCOS. The quality of evidence is generally good for specific compounds, though less direct evidence exists for whole ovarian extracts.

Benefits

Myo-inositol supplementation significantly improves the rate of mature (MII) oocytes and fertilization rates in women undergoing IVF, as evidenced by statistically significant odds ratios and mean differences reported in meta-analyses. This benefit is clinically relevant for optimizing fertility treatment outcomes. Flavonoid supplementation may enhance follicular development and promote ovarian cell proliferation and differentiation, offering potential benefits for women with PCOS. Both myo-inositol and flavonoids can lead to improved hormonal profiles and ovarian response, particularly in women identified as poor responders to fertility treatments. These benefits are most pronounced in infertile women undergoing IVF, women with PCOS, and those with poor ovarian response. The time course for observing benefits typically aligns with fertility treatment protocols, ranging from weeks to months.

How it works

Myo-inositol functions primarily as a second messenger in insulin signaling pathways. By improving ovarian sensitivity to insulin, it facilitates proper oocyte maturation and overall ovarian function. Flavonoids, on the other hand, exert their effects through antioxidant properties and by modulating various signaling pathways crucial for follicular development and steroidogenesis. Both compounds primarily interact with the reproductive and endocrine systems. Their known molecular targets include insulin receptors, follicle-stimulating hormone (FSH) pathways, and pathways involved in mitigating oxidative stress. Myo-inositol is well absorbed orally, while the bioavailability of flavonoids can vary depending on the specific compound and its formulation.

Side effects

Supplements targeting ovarian function, particularly myo-inositol and flavonoids, are generally considered safe with a low incidence of adverse effects when used at recommended doses. The most common side effect reported with myo-inositol is mild gastrointestinal discomfort, which occurs occasionally. Uncommon side effects (1-5% incidence) may include rare allergic reactions or mild headaches. Serious adverse events are rare, with no significant concerns reported in high-quality studies. No significant drug interactions have been widely reported; however, caution is advised when these supplements are combined with insulin or other hormonal therapies due to potential additive effects. Contraindications include hypersensitivity to any of the components. Use in pregnant or breastfeeding women should always be under medical supervision. Overall, the safety profile is favorable, but individual responses can vary.

Dosage

For myo-inositol, studies have shown efficacy at doses around 2 grams taken twice daily. The optimal dosage range for myo-inositol is typically 2-4 grams per day. The maximum safe dose for myo-inositol is generally considered to be up to 4 grams per day. For flavonoids, dosage varies widely depending on the specific compound and its intended use. Supplementation is usually initiated before and continued throughout fertility treatment cycles to maximize benefits. Oral formulations, available as powders or capsules, are preferred. Taking these supplements with meals may help improve gastrointestinal tolerance. Sometimes, myo-inositol is combined with cofactors like folic acid or other antioxidants to enhance its effects.

FAQs

Is ovarian extract supplementation effective?

Direct ovarian extracts are not commonly used. Instead, compounds like myo-inositol and certain flavonoids are evidence-backed for improving ovarian function and fertility outcomes.

Are these supplements safe?

Yes, when used as recommended, supplements like myo-inositol and flavonoids have a good safety profile with generally mild and infrequent side effects.

When should I take these supplements?

For best effect, it is recommended to start taking these supplements before and continue throughout fertility treatment cycles.

How soon can I expect results?

Improvements in oocyte quality and fertilization rates may be observed within treatment cycles, typically within weeks to a few months of consistent use.

Are there misconceptions about these supplements?

While these supplements can improve chances in assisted reproduction, they cannot guarantee pregnancy. They are meant to support and optimize ovarian function.

Research Sources

https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1520362/full – This systematic review and meta-analysis, including multiple RCTs, found that myo-inositol supplementation significantly improves mature oocyte rates and fertilization rates in IVF patients. The study supports its use in fertility treatment, though it notes heterogeneity among studies and calls for more high-quality RCTs.
https://academic.oup.com/nutritionreviews/article/83/3/e829/7718009 – This updated meta-analysis on flavonoid supplementation in PCOS suggests that flavonoids enhance follicular development and ovarian cell function. The findings indicate potential benefits for PCOS management, although the study highlights variability in flavonoid types and doses, and limited long-term data.
https://pubmed.ncbi.nlm.nih.gov/31165401/ – This randomized clinical trial investigated myo-inositol in poor ovarian responders. It concluded that myo-inositol improved fertility rates and ovarian response in these patients undergoing assisted reproductive techniques. The study was single-center, suggesting a need for further multicenter trials.